121 related articles for article (PubMed ID: 36402716)
1. A new upper limit for effective dose in patient administered with 18F-FDG for PET/CT whole-body imaging with diagnostic CT parameters.
Velo P; Ismail MI; Mohandas KK; Kasilingam L
J Med Imaging Radiat Sci; 2023 Mar; 54(1):43-50. PubMed ID: 36402716
[TBL] [Abstract][Full Text] [Related]
2. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
[TBL] [Abstract][Full Text] [Related]
3. An Australian local diagnostic reference level for paediatric whole-body
Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
[TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
Willowson KP; Bailey EA; Bailey DL
Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
[TBL] [Abstract][Full Text] [Related]
5. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
[TBL] [Abstract][Full Text] [Related]
6. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic reference levels for
Alkhybari EM; McEntee MF; Brennan PC; Willowson KP; Kench PL
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):291-299. PubMed ID: 30770654
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Radiation Exposure to Workers During [
Al-Aamria M; Al-Balushia N; Bailey D
J Med Imaging Radiat Sci; 2019 Dec; 50(4):565-570. PubMed ID: 31447232
[TBL] [Abstract][Full Text] [Related]
10. Weight-based, low-dose pediatric whole-body PET/CT protocols.
Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
[TBL] [Abstract][Full Text] [Related]
11. Quantification of DNA damage in patients undergoing non-contrast and contrast enhanced whole body PET/CT investigations using comet assay and micronucleus assay.
Nautiyal A; Mondal T; Mukherjee A; Mitra D; Kaushik A; Goel HC; Goel A; Dey SK
Int J Radiat Biol; 2019 Jun; 95(6):710-719. PubMed ID: 30707050
[No Abstract] [Full Text] [Related]
12. Significantly Low Effective Dose from 18FDG PET/CT Scans Using Dose Reducing Strategies: "Lesser is Better".
Zaman MU; Fatima N; Zaman A; Zaman U; Tahseen R
Asian Pac J Cancer Prev; 2016; 17(7):3465-8. PubMed ID: 27509993
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
15. EFFECTIVE DOSE ESTIMATION IN WHOLE BODY 18F-FDG PET/CT IMAGING.
Karimipourfard M; Sina S; Shobeiry M; Alavi MS; Faghihi R
Radiat Prot Dosimetry; 2022 Oct; 198(18):1444-1449. PubMed ID: 36043426
[TBL] [Abstract][Full Text] [Related]
16. EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE?
Li Y; Jiang L; Wang H; Cai H; Xiang Y; Li L
Radiat Prot Dosimetry; 2019 Dec; 187(2):183-190. PubMed ID: 31147708
[TBL] [Abstract][Full Text] [Related]
17. Reduction of
Sekine T; Delso G; Zeimpekis KG; de Galiza Barbosa F; Ter Voert EEGW; Huellner M; Veit-Haibach P
Radiology; 2018 Jan; 286(1):249-259. PubMed ID: 28914600
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
[TBL] [Abstract][Full Text] [Related]
19. ESTIMATION OF PATIENT ORGAN AND WHOLE-BODY DOSES IN [18F-FDG] PET/CT SCAN.
Kessara A; Buyukcizmeci N; Gedik GK
Radiat Prot Dosimetry; 2023 Jan; 199(1):61-68. PubMed ID: 36379473
[TBL] [Abstract][Full Text] [Related]
20. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
